# Feasibility Assessment of the Wellumio 'Axana' 0.1T Portable MRI Device

> **NCT07751328** · NA · COMPLETED · sponsor: **Wellumio R&D Australia Pty Ltd** · enrollment: 60 (actual)

## Conditions studied

- Stroke
- Acute Stroke
- Ischemic Stroke
- Hemorrhagic Stroke

## Interventions

- **DIAGNOSTIC_TEST:** Axana Scan and MRI

## Key facts

- **NCT ID:** NCT07751328
- **Lead sponsor:** Wellumio R&D Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751328, "Feasibility Assessment of the Wellumio 'Axana' 0.1T Portable MRI Device". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*